Data protection Impressum

Pharma

Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics

2 February 2022

ObsEva achieves positive results in the treatment of endometriosis

12 January 2022

Pharma group Siegfried invests in Valais and creates 40 jobs

14 December 2021

Inflamalps takes part in a significant biopharmaceutical research project

16 November 2021

Valais biotech Novochizol wins an international competition

13 October 2021

University of Bern spin-off Arctos Medical acquired by Novartis

22 September 2021

INVENesis’ testing system speeds the development of antiparasitic drugs

31 August 2021

The partnership between Lonza and the HES-SO Valais-Wallis is yielding results

31 August 2021

Debiopharm launches IDEAL, a new hub for life sciences

17 August 2021

Women’s health biopharmaceutical company ObsEva receives USD 500 million

10 August 2021

1 … 8 9 10 11 12 13 14 15